Inogen Sells Rental Oxygen Business to Rotech

BEVERLY, Massachusetts—Respiratory company Inogen is selling its United States oxygen rental business to Rotech Healthcare for about $25 million, the company reported. The transaction is expected to close in the fourth quarter of 2026.

Inogen also signed a new long-term supply agreement with Rotech with the goal of meeting demand for Inogen’s oxygen concentrators through Rotech’s national distribution network.

Inogen plans to focus on its core competencies in respiratory innovation and to work with home medical equipment (HME) providers to expand the number of patients using its products, the company said in a news release. The transaction will allow it to “operate through a simpler, more focused business model designed to drive greater patient access, faster growth and improved profitability,” it said. The company included FAQs for HME providers on its website.

“These transactions strengthen our business and financial profile, sharpen our strategic focus, and enable us to continue investing in innovative solutions that improve patient outcomes,” said Inogen President and CEO Kevin Smith. “Rotech’s strong reputation and respiratory care expertise makes it a proven and trusted partner for our patients. Together, we are focused on providing a smooth transition for patients and ensuring continued access to high-quality oxygen therapy solutions.”

Inogen said it expects the transactions to increase both the revenue growth rate and adjusted operating income. Its rental business generated revenue of $24.3 million in the first half of 2026, representing a year-over-year decline of 9.8%.